Luke Moore to Prospective Studies
This is a "connection" page, showing publications Luke Moore has written about Prospective Studies.
Connection Strength
0.064
-
Near-patient SARS-CoV-2 molecular platforms: new-old tools for new-old problems. Lancet Respir Med. 2020 12; 8(12):1161-1163.
Score: 0.036
-
Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis. J Infect. 2021 10; 83(4):452-457.
Score: 0.010
-
Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
Score: 0.009
-
Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence. Clin Microbiol Infect. 2020 Dec; 26(12):1711-1713.
Score: 0.009